Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02402244 · ClinicalTrials.gov registry record
Project: Every Child for Younger Patients With Cancer
A clinical trial of Central Nervous System Neoplasm and Carcinoma in Situ, sponsored by Children's Oncology Group.
- Recruiting
- Registry status
- 75,000
- Enrollment target
- 20
- Study locations
NCT02402244: Recruiting study of Central Nervous System Neoplasm and Carcinoma in Situ, sponsored by Children's Oncology Group.
NCT02402244 is a study of Central Nervous System Neoplasm and Carcinoma in Situ that is actively recruiting participants, run by Children's Oncology Group. The registered enrollment target is 75,000 participants, above the 126-participant average among 7 other Central Nervous System Neoplasm trials with a reported enrollment target (59424% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02402244, a study of Central Nervous System Neoplasm and Carcinoma in Situ, is actively recruiting participants, sponsored by Children's Oncology Group.
- RECRUITING
- Registry status
- 75,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Primary Outcome
The number of patients who agree to be in the Biobanking part of the study and have leftover tumor tissue and some normal blood, bone marrow, or other tissue saved for future research.
Conditions Studied
Interventions
- OTHER Medical Chart Review
- OTHER Cytology Specimen Collection Procedure
Study Locations (20)
California
- Kaiser Permanente Downey Medical Center - Downey
- City of Hope Comprehensive Cancer Center - Duarte
- Loma Linda University Medical Center - Loma Linda
- Miller Children's and Women's Hospital Long Beach - Long Beach
- Children's Hospital Los Angeles - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- Mattel Children's Hospital UCLA - Los Angeles
- Valley Children's Hospital - Madera
- UCSF Benioff Children's Hospital Oakland - Oakland
- Kaiser Permanente-Oakland - Oakland
- Children's Hospital of Orange County - Orange
- Lucile Packard Children's Hospital Stanford University - Palo Alto
Arizona
- Kingman Regional Medical Center - Kingman
- Banner Children's at Desert - Mesa
- Phoenix Childrens Hospital - Phoenix
- Banner University Medical Center - Tucson - Tucson
Alabama
- Children's Hospital of Alabama - Birmingham
- USA Health Strada Patient Care Center - Mobile
Alaska
- Providence Alaska Medical Center - Anchorage
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75,000 participants |
| Start Date | 2015-11-03 |
| Est. Completion | 2030-12-31 |
What NCT02402244 shows while recruiting
NCT02402244 is an observational study that tracks outcomes without assigning an intervention. Its 75,000 participants enrollment target places it among the larger protocols in the corpus, above the 126-participant average among 7 other Central Nervous System Neoplasm trials with a reported enrollment target (59424% higher).
The record links to 10 conditions, with Central Nervous System Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT02402244 names 20 study sites across 5 states, led by California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT02402244 about?
NCT02402244 is a clinical study titled "Project: Every Child for Younger Patients With Cancer". This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
What is the current status of trial NCT02402244?
This trial is currently recruiting. The enrollment target is 75,000 participants. The study started on 2015-11-03. Estimated completion is 2030-12-31.
What conditions does trial NCT02402244 study?
This clinical trial studies the following conditions: Central Nervous System Neoplasm, Carcinoma in Situ, Desmoid Fibromatosis, Adrenal Gland Pheochromocytoma, Ganglioneuroma.
What interventions are being tested in trial NCT02402244?
The interventions under investigation include: Medical Chart Review (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02402244?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02402244 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Nervous System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
RECRUITING
-
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
RECRUITING · Phase 2
-
Cerebrospinal Fluid Biomarkers for Brain Tumors
RECRUITING
-
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
ACTIVE NOT RECRUITING · Phase 2
-
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
ACTIVE NOT RECRUITING · Phase 2
-
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02803242 · 75,000 participants
COPD Patient-Powered Research Network
- NCT04611568 · 75,000 participants · NA
War on Melanoma™ Public Health & Education Campaign
- NCT00063063 · 80,000 participants
Generic Database of Very Low Birth Weight Infants
- NCT06625983 · 80,000 participants · NA
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI